Pre-market strategy for April 2

Personal trading notes: (In 25, luck helped me double; fans who watch my daily recaps in 25 should be making more than I am! In 2026, we’ll keep moving forward!)

HuaDian Energy : Pay attention to the board on 3/13; take-profit and unfollow on 3/16 after +6%
RisKangDa: Pay attention to the low buy on the 5-day line on 3/19; take-profit and unfollow after hitting the daily limit and breaking the board on 3/20
HuaDian LiaoNeng: Pay attention to the board on 3/23; enter the limit-up and choose to hold with a bigger mindset for unusual moves on 3/24; continue challenging the unusual-move pattern with another limit-up on 3/25; take-profit and unfollow after breaking the board on 3/26
ShaoNeng Co., Ltd.: Pay attention to the board on 3/25; take-profit and unfollow with a loss of -4% on 3/26
ShenJian Co., Ltd.: Pay attention to the board on 3/31; take-profit and unfollow on 4/1 after +5%

Next I’ll share some practical tips with you brothers—keep scrolling down. If you think what I write is good and it improves your stock-trading awareness, or if your account has been reaping fruitful results thanks to my recaps, then feel free to tip and support the creator with “oil”—your support is the motivation for me to keep updating!

Core targets: JinYao Pharmaceutical ( 600488 ) — the only one breaking the deadlock

Core logic: It’s the only 4-board stock in the whole market. It’s the current sentiment cycle’s “lone sprout” and a “stress test point.” Tomorrow, if it can advance to 5 boards, it will break the recent 4-board ceiling left behind by RongJie Co., Ltd., ShenJian Co., Ltd., etc., and only then will there be a chance for sentiment to recover; if it breaks the board and fails, the consecutive-limit height will return to 2–3 boards, and a new “ice point” phase will begin.

Board-trade conditions (each one is required—can’t miss any):

1. Must go through “divergence and turnover”: Today is a T board with huge profit-taking. Tomorrow’s early session—if it keeps topping with a one-price limit or gaps high and instantly locks the board, give up directly—most likely it will be smashed to ruin by trapped holders. The board that’s truly worth trading is the moment it reverses and rallies to board up after early-session divergence and a selloff (oscillating within -3% to +3%), with turnover rate exceeding 10%–15%.
2. Must have “sector tailwinds”: When it goes up on the board, the pharma sector must not show significant negative feedback. Ideally, there should be newly listed pharma stocks that hit the limit-up first, or major/20cm names such as KaiLiYing and RuiZhi Pharma should stay strongly red.
3. Must show an “emotion reversal” signal: When placing the board trade, watch the power stocks that were down-limit yesterday (HuaDian LiaoNeng, GuangXi Energy) to see whether they open from the down-limit or stop falling and turn red. If they’re still being liquidated, it means the loss-making effect is still spreading—then any board should be handled cautiously.

If JinYao Pharmaceutical doesn’t meet the conditions of “divergence-and-turnover + sector tailwinds” above, but instead simply weakens, then there will be no consecutive-limit target in the whole market worth debating.

Alternate to watch: TongDa Shares ( 002560 ) — arbitrage with independent logic

Core logic: It doesn’t belong to the pharma main theme. It’s driven by independent logic: ultra-high voltage power transmission + defense and military + earnings growth anticipation. In a downturn/decline period, stocks like this sometimes can run an “independent行情” that doesn’t rely on the sector—similar to FengLong Shares back then. Today’s high turnover (18.46%) has fully released the divergence. If tomorrow pharma divergence intensifies, funds may split and search for targets driven by independent logic.

Board-trade conditions (strictly limited):

1. Only for “weak-to-strong” board trading: Tomorrow it must gap up (+3% or more), and after the open it must quickly surge, strongly locking the board before 9:45. If it gaps down or opens flat and then chops around, it means the independent logic isn’t recognized—give up immediately.
2. Only allowed to trade “the second lock”: This kind of non-mainline stock easily gets a failed lock. You must wait until it first breaks (fails to hold the board), then observe the follow-through. If it can lock back up and the order queue is firm, then consider trading it again on the re-lock.

Absolutely forbidden board-trade targets

· XinZhongGang ( 605162 ): A follow-on from the power sector. The sector leaders are all getting sliced in A-kill; follow-on stocks that get board-traded are very likely to open low and get shut down the next day.
· KaiLiYing ( 002821 ): An institutional trend stock. It has weak characteristics for consecutive-limit boards; the cost-performance of board trading is extremely low, and it’s easy to be sold off by institutions.
· XingHui HuanCai ( 300834 ): 20cm two consecutive limit-ups. In a decline/withdrawal period, the risk of taking 20cm in a relay is extremely high. Once it fails, intraday losses could exceed 15%.

One more time to emphasize at the end: In a cycle where the consecutive-limit advancement rate is only 12.5% and all mid-tier stocks are completely cut off, the win rate of board trading is inherently very low. If tomorrow JinYao Pharmaceutical doesn’t meet the “turnover + re-lock after closure” standard, then staying in cash is itself the best trade.

Thanks to the following brothers and sisters for your tips—wishing everyone a full position and limit-up gains! Also, I’ll take seriously and think through the questions you ask in the comments section, and help you improve your stock-trading awareness!
@RedFireFireEmotionCycle@GreenClothingPerson@XiangWei@YangXiaoYangYi@008Wind@DesertCamel2020@LiuXiaoFeng@PoolInWater@GeShallow520@MaDaXuanFeng@YangXi @ZhuangMengLanDie@EnableBrother@DesertCamel2020@OneJuDingQianKun@PoolInWater